LYNC-101

· LyncBio Therapeutics Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LYNC-101, covering 2026-04-17 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of LYNC-101 for Injection in Healthy Adult Participants [Phase 1]

See pricing